Month: September 2010

Genzyme Corp confirmed that it has received an unsolicited, non-binding proposal from Sanofi-Aventis to acquire all the outstanding shares of Genzyme for $69 per share in cash. The Genzyme board of directors met last night, unanimously affirmed its previous rejection.

MarketResearch.com has announced the addition of TriMark Publications’s new report “Point of Care Diagnostic Testing World Markets,” to their collection of In Vitro Diagnostics market reports.

InoLife Technologies announced it will provide and market a proprietary metabolizing test to physicians and practitioners to identify how a patient’s genetic makeup may affect the body’s response to Plavix (colpidogrel).

Anne Rimoin, an assistant professor of epidemiology at the UCLA School of Public Health, and colleagues report that 30 years after the mass smallpox vaccination campaign ceased, rates of a related virus known as human monkeypox have increased dramatically in the rural Democratic Republic of Congo.